METHYLPHENIDATE Spirig HC cpr ret 18 mg bte 60 pce

7680693150027 CH-69315 N06BA04 01.10.2.

Reimbursement limitations:

FOCALIN XR

Pose du diagnostic par un médecin spécialiste (pédiatre/psychiatre), expert dans le traitement du TDAH,
Traitement …

METHYLPHENIDATE Spirig HC cpr ret 18 mg bte 60 pce
METHYLPHENIDATE Spirig HC cpr ret 18 mg bte 60 pce
METHYLPHENIDATE Spirig HC cpr ret 18 mg bte 60 pce
1 / 3
google

Details

Product number
6931501
CPT
-
Packaging group
60
Unit
Tablette(n)
Composition
methylphenidati hydrochloridum 18 mg, hypromellosum, macrogolum 200'000, macrogolum 7'000'000, acidum succinicum, magnesii stearas, natrii chloridum corresp. natrium 9.4 mg, silica colloidalis anhydrica, E 172 (nigrum), Überzug: cellulosi acetas, hypromellosum, macrogolum 3350, lactosum monohydricum 4 mg, E 171, triacetinum, E 172 (flavum), E 172 (rubrum), acidum phosphoricum, pro compresso obducto.

Articles (1)

Methylphenidat Spirig HC retard 18 mg, Retardtabletten
Tabletten
60
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
23/08/2024
Patient information leaflet
Français
23/08/2024
Patient information leaflet
Italien
23/08/2024
Professional SmPC
Allemand
23/08/2024
Professional SmPC
Français
23/08/2024
Professional SmPC
Italien
23/08/2024

Detailed composition

Substance Quantity Type Category
(N/A)
18.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
9.4 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
4.0 MG Substance HBESI
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 67.80
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/10/2024

Authorization holder

Spirig HealthCare AG

4622 Egerkingen

Authorization information

Swissmedic authorization number
69315
Drug name
Methylphenidat Spirig HC retard, Retardtabletten
Galenic form
RETT
ATC Code
N06BA04
Authorization status
Z
Dispensation category
A+
First authorization
04/01/2024
Authorization expiration date
03/01/2029
IT number
01.10.2.
Domain
Human medicine
Field of application
Zentral wirkendes Sympathomimetikum

Packaging details

Description (FR)
METHYLPHENIDATE Spirig HC cpr ret 18 mg bte 60 pce
Description (DE)
METHYLPHENIDAT Spirig HC Ret Tabl 18 mg Ds 60 Stk
Market launch
04/01/2024
Narcotic (BTM)
A

Original drug

Concerta, Retardtabletten
CHF 48.35
View original

Other packaging sizes

METHYLPHENIDATE Spirig HC cpr ret 18 mg bte 30 pce
30 TABL
View
METHYLPHENIDATE Spirig HC cpr ret 27 mg bte 30 pce
30 TABL
View
METHYLPHENIDATE Spirig HC cpr ret 27 mg bte 60 pce
60 TABL
View
METHYLPHENIDATE Spirig HC cpr ret 36 mg bte 30 pce
30 TABL
View
METHYLPHENIDATE Spirig HC cpr ret 36 mg bte 60 pce
60 TABL
View
METHYLPHENIDATE Spirig HC cpr ret 54 mg bte 30 pce
30 TABL
View
METHYLPHENIDATE Spirig HC cpr ret 54 mg bte 60 pce
60 TABL
View